These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 32306615)
21. Ranibizumab for macular edema due to retinal vein occlusions: long-term follow-up in the HORIZON trial. Heier JS; Campochiaro PA; Yau L; Li Z; Saroj N; Rubio RG; Lai P Ophthalmology; 2012 Apr; 119(4):802-9. PubMed ID: 22301066 [TBL] [Abstract][Full Text] [Related]
22. Two or more dexamethasone intravitreal implants in treatment-naïve patients with macular edema due to retinal vein occlusion: subgroup analysis of a retrospective chart review study. Dugel PU; Capone A; Singer MA; Dreyer RF; Dodwell DG; Roth DB; Shi R; Walt JG; Scott LC; Hollander DA; BMC Ophthalmol; 2015 Sep; 15():118. PubMed ID: 26337664 [TBL] [Abstract][Full Text] [Related]
23. Pharmacotherapy for treatment of retinal vein occlusion. Sarao V; Bertoli F; Veritti D; Lanzetta P Expert Opin Pharmacother; 2014 Nov; 15(16):2373-84. PubMed ID: 25190137 [TBL] [Abstract][Full Text] [Related]
24. Association of aqueous humor cytokines with the development of retinal ischemia and recurrent macular edema in retinal vein occlusion. Jung SH; Kim KA; Sohn SW; Yang SJ Invest Ophthalmol Vis Sci; 2014 Apr; 55(4):2290-6. PubMed ID: 24398091 [TBL] [Abstract][Full Text] [Related]
26. Retinal vein thrombosis: pathogenesis and management. Rehak M; Wiedemann P J Thromb Haemost; 2010 Sep; 8(9):1886-94. PubMed ID: 20492457 [TBL] [Abstract][Full Text] [Related]
27. The anti-inflammatory and anti-oxidative effects of conbercept in treatment of macular edema secondary to retinal vein occlusion. Xia JP; Wang S; Zhang JS Biochem Biophys Res Commun; 2019 Jan; 508(4):1264-1270. PubMed ID: 30558792 [TBL] [Abstract][Full Text] [Related]
28. Comparison of ranibizumab alone versus ranibizumab with targeted retinal laser for branch retinal vein occlusion with macular edema. Goel S; Kumar A; Ravani RD; Chandra P; Chandra M; Kumar V Indian J Ophthalmol; 2019 Jul; 67(7):1105-1108. PubMed ID: 31238421 [TBL] [Abstract][Full Text] [Related]
32. Subthreshold grid laser versus intravitreal bevacizumab as second-line therapy for macular edema in branch retinal vein occlusion recurring after conventional grid laser treatment. Parodi MB; Iacono P; Bandello F Graefes Arch Clin Exp Ophthalmol; 2015 Oct; 253(10):1647-51. PubMed ID: 25382074 [TBL] [Abstract][Full Text] [Related]
33. [The use of anti-angiogenic drugs for central retinal vein occlusion]. Waisbourd M; Loewenstein A Harefuah; 2010 Apr; 149(4):243-4, 261. PubMed ID: 20812499 [TBL] [Abstract][Full Text] [Related]
34. Peripheral Laser for Recalcitrant Macular Edema Owing to Retinal Vein Occlusion: The WAVE Trial. Wykoff CC; Ou WC; Wang R; Brown DM; Cone C; Zamora D; Le RT; Sagong M; Wang K; Sadda SR; Ophthalmology; 2017 Jun; 124(6):919-921. PubMed ID: 28318636 [No Abstract] [Full Text] [Related]
35. Combination of peripheral laser photocoagulation with intravitreal bevacizumab in naïve eyes with macular edema secondary to CRVO: prospective randomized study. Chhablani J; Narayanan R; Mathai A; Tyagi M Eye (Lond); 2016 Jul; 30(7):1025-7. PubMed ID: 27034198 [No Abstract] [Full Text] [Related]
36. Impact of Intravitreal Ranibizumab on Vessel Functionality in Patients With Retinal Vein Occlusion. Corvi F; La Spina C; Benatti L; Querques L; Lattanzio R; Bandello F; Querques G Am J Ophthalmol; 2015 Jul; 160(1):45-52.e1. PubMed ID: 25896458 [TBL] [Abstract][Full Text] [Related]